Experimental photodynamic effects of hypocrellin A on the choriocapillaris

Ophthalmic Surgery and Lasers

Volumn 33, Issue 3, 2002, Pages 207-213

  Khoobehi, Bahram ^a   Grinstead, Robert ^a   Passos, Elke ^a  

^a LSU EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOCRELLIN A; PHOTOSENSITIZING AGENT; DRUG DERIVATIVE; PERYLENE; QUINONE DERIVATIVE; LIPOSOME;

ABSORPTION SPECTROPHOTOMETRY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHOROID CAPILLARY LAYER; CONTROLLED STUDY; DYE LASER; FLUORESCENCE ANGIOGRAPHY; HISTOLOGY; IRRADIATION; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RABBIT; ANIMAL; CAPILLARY; CHOROID; DRUG EFFECT; EYE FUNDUS; LASER; PATHOLOGY; PHOTOCHEMOTHERAPY; VASCULARIZATION; ANIMAL MODEL; DRUG EFFICACY; DRUG RESPONSE; MICROSCOPY; PHOTODYNAMICS; PIGMENTATION; RETINA;

ANIMAL; CAPILLARIES; CHOROID; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; LASERS; PERYLENE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; QUINONES; RABBITS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS;

EID: 0036000130     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. The Framingham Eye Study. I. Outline and major prevalence findings
2. Senile macular degeneration: Review of epidemiologic features
3. Prevalence of age-related maculopathy. The Beaver Dam Eye Study
4. Senile macular degeneration: A case control study
5. Growth rate of sub-retinal neovascularization in age-related macular degeneration
6. Subretinal neovascularization in senile macular degeneration
7. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of a single treatment in a phase 1 and 2 study
8. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: Results of retreatments in a phase 1 and 2 study
9. Dye-sensitized photodynamic inactivation of cells
10. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor
11. Hypocrellin A, a new drug for photochemotherapy
12. Hypocrellins and their use in photosensitization
13. Photodynamic effects of hypocrellin A on three human malignant cell lines by inducing apoptotic cell death
14. Hypocrellin, from Hypocrella bambusae, is phototoxic to human immunodeficiency virus
15. Hypocrellins as photosensitizers for photodynamic therapy: A screening evaluation and pharmacokinetic study
16. Roles of oxygen and photoinduced acidification in the light-dependent antiviral activity of hypocrellin A
17. Photosensitization by anticancer agents. 12. Perylene quinoid pigments, a novel type of singlet oxygen sensitizer
18. Uptake kinetics and intracellular localization of hypocrellin photosensitizers for photodynamic therapy: A confocal microscopy study
19. EPR-spin trapping kinetic studies of superoxide radicals produced by photosensitized hypocrellin A. A photodynamic therapeutic agent
20. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation
21. Role of neovasculature and vascular permeability on the tumor retention of photodynamic agents
22. Lutetium texaphyrin (Lu-Tex): A potential new agent for ocular fundus angiography and photodynamic therapy
23. Selective photodynamic effects of the new photosensitizer ATX-S10(Na) on choroidal neovascularization in monkeys
24. Clinical exacerbation of systemic lupus erythematosus after photodynamic therapy of laryngotracheal papillomatosis
25. Verteporfin
26. Pharmacokinetics, tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy
27. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin
28. Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2)
29. 18O labelling
30. Generation of free radicals during photosensitization of hypocrellin A and their effects on cardiac membranes